These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18348652)

  • 21. [Enhancing effects of celecoxib on the growth inhibition of pancreatic carcinoma by gemcitabine treatment].
    Xu G; Wu K; Wang XP; Zhao S
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):986-91. PubMed ID: 16060994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JS‑K induces G2/M phase cell cycle arrest and apoptosis in A549 and H460 cells via the p53/p21WAF1/CIP1 and p27KIP1 pathways.
    Song Z; Yin Y; Hao S; Wei J; Liu B; Huang X; Gao C; Zhu R; Liao W; Cai D
    Oncol Rep; 2019 Jun; 41(6):3475-3487. PubMed ID: 31002373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NFV, an HIV-1 protease inhibitor, induces growth arrest, reduced Akt signalling, apoptosis and docetaxel sensitisation in NSCLC cell lines.
    Yang Y; Ikezoe T; Nishioka C; Bandobashi K; Takeuchi T; Adachi Y; Kobayashi M; Takeuchi S; Koeffler HP; Taguchi H
    Br J Cancer; 2006 Dec; 95(12):1653-62. PubMed ID: 17133272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological comparison of adenocarcinoma of cervix and endometrium using cell cycle markers: P16ink4a, P21waf1, and p27Kip1 on 132 cancers.
    Abu Backer FM; Nik Mustapha NR; Othman NH
    Infect Dis Obstet Gynecol; 2011; 2011():857851. PubMed ID: 22114462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway.
    Singh SK; Banerjee S; Acosta EP; Lillard JW; Singh R
    Oncotarget; 2017 Mar; 8(10):17216-17228. PubMed ID: 28212547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E(2)-independent mechanisms.
    Deasy BM; O'Sullivan-Coyne G; O'Donovan TR; McKenna SL; O'Sullivan GC
    Cancer Lett; 2007 Oct; 256(2):246-58. PubMed ID: 17707579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Schedule-dependent synergistic interaction between gemcitabine and oxaliplatin in human gallbladder adenocarcinoma cell lines.
    Makiyama A; Qin B; Uchino K; Shibata Y; Arita S; Isobe T; Hirano G; Kusaba H; Baba E; Akashi K; Nakano S
    Anticancer Drugs; 2009 Feb; 20(2):123-30. PubMed ID: 19209029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclooxygenase-2 overexpression inhibits platelet-derived growth factor-induced mesangial cell proliferation through induction of the tumor suppressor gene p53 and the cyclin-dependent kinase inhibitors p21waf-1/cip-1 and p27kip-1.
    Zahner G; Wolf G; Ayoub M; Reinking R; Panzer U; Shankland SJ; Stahl RA
    J Biol Chem; 2002 Mar; 277(12):9763-71. PubMed ID: 11756433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ERK phosphorylation predicts synergism between gemcitabine and the epidermal growth factor receptor inhibitor AG1478.
    Luk PP; Galettis P; Links M
    Lung Cancer; 2011 Sep; 73(3):274-82. PubMed ID: 21277645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential modulation of paclitaxel-mediated apoptosis by p21Waf1 and p27Kip1.
    Schmidt M; Lu Y; Liu B; Fang M; Mendelsohn J; Fan Z
    Oncogene; 2000 May; 19(20):2423-9. PubMed ID: 10828884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma.
    Cheng JD; Werness BA; Babb JS; Meropol NJ
    Clin Cancer Res; 1999 May; 5(5):1057-62. PubMed ID: 10353738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanism and effect of selective cyclooxygenase-2 inhibitor NS-398 on human cervical carcinoma cells].
    Li XG; Wu M; Zhang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 32(5):877-82. PubMed ID: 18007088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interplay Between Gemcitabine and Erlotinib Over Pancreatic Adenocarcinoma Cells.
    Torres C; Linares A; Alejandre MJ; Palomino-Morales RJ; Delgado JR; Perales S
    Pancreas; 2016 Feb; 45(2):269-80. PubMed ID: 26495790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines.
    Tolis C; Peters GJ; Ferreira CG; Pinedo HM; Giaccone G
    Eur J Cancer; 1999 May; 35(5):796-807. PubMed ID: 10505042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NS398 induces apoptosis in non-small cell lung cancer cells.
    Qiu R; Chen J; Sima J; Shen X; Liu D; Shen J
    J Cancer Res Clin Oncol; 2012 Jan; 138(1):119-24. PubMed ID: 22048655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P300 inhibition enhances gemcitabine-induced apoptosis of pancreatic cancer.
    Ono H; Basson MD; Ito H
    Oncotarget; 2016 Aug; 7(32):51301-51310. PubMed ID: 27322077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel strategy of EGFR‑TKI combined chemotherapy in the treatment of human lung cancer with EGFR‑sensitive mutation.
    Zhang L; Qi Y; Xing K; Qian S; Zhang P; Wu X
    Oncol Rep; 2018 Aug; 40(2):1046-1054. PubMed ID: 29917169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1.
    Kim MK; Jeon YK; Woo JK; Choi Y; Choi DH; Kim YH; Kim CW
    Mol Cancer; 2011 Aug; 10():98. PubMed ID: 21843371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective Nuclear Export Inhibitor KPT-330 Enhances the Antitumor Activity of Gemcitabine in Human Pancreatic Cancer.
    Kazim S; Malafa MP; Coppola D; Husain K; Zibadi S; Kashyap T; Crochiere M; Landesman Y; Rashal T; Sullivan DM; Mahipal A
    Mol Cancer Ther; 2015 Jul; 14(7):1570-81. PubMed ID: 25934708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells.
    Lee TH; Chuang LY; Hung WC
    Oncogene; 1999 Jul; 18(29):4269-74. PubMed ID: 10435640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.